The Tandem Mobi is fully controllable from a mobile app and is the world's smallest durable automated insulin delivery system, the company said. "Testing the limits of pump miniaturization, Tandem Mobi joins the t:slim X2 pump in our family of insulin delivery solutions bringing new options in wearability, the flexibility to disconnect, and full phone control," said John Sheridan, president and CEO. "Through this expansion, we are delivering on our commitment to bring greater choice, along with the proven benefits of Tandem's technology, to more people living with diabetes." [Read more: Driving innovation in diabetes care ] The Tandem Mobi features a 200-unit insulin cartridge and an on-pump button that provides an alternative option to phone control for bolusing insulin. Additional features include: A limited release of Tandem Mobi is expected to start in late 2023 with full commercial availability planned in early 2024.